CBLL: Revenue grew 30%, but higher spending widened Q3 losses as hospital adoption passed 700

Less than 1 min read

Q3 revenue grew 30% YoY to $29.3M, while net loss widened to $21.4M as operating costs rose. Adoption exceeded 700 hospitals, with 2026 clearances broadening the product portfolio and $117.5M in cash and marketable securities supporting at least 12 months of planned needs.

Original document: [CeriBell, Inc. [CBLL] SEC 10-Q Quarterly Report — Nov. 3 2026](https://www.tradingview.com/accounts/signin?next=https%3A%2F%2Fnews-mediator.tradingview.com%2Fdoc-screener%2Fv1%2Ffiles%2Furn%3Areport%3Aquartr.com%3A3992247-86d358b0eb8374facec918cbe474bf96)

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.